[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]

[[ timeLabel ]] WATCH LIVE:

Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial

Faster, Cleaner, Better.

Regulus Therapeutics (RGLS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2014	12-2013	12-2012	12-2011	12-2010
Assets
Current Assets
Cash & Cash Equivalents	37,327	17,807	40,552	9,175	N/A
Marketable Securities	122,416	96,198	57,548	28,969	N/A
Receivables	274	79	0	N/A	N/A
Other current assets	742	0	0	0	0
TOTAL	$164,951	$117,182	$98,929	$38,666	$N/A

Non-Current Assets
PPE Net	3,568	3,768	3,310	3,110	N/A
Intangibles	1,150	1,128	1,154	980	0
Other Non-Current Assets	1,811	987	125	125	0
TOTAL	$6,529	$5,883	$4,589	$4,215	$N/A

Total Assets	$171,480	$123,065	$103,518	$42,881	$N/A

Liabilities
Current Liabilities
Short Term Debt	23,397	N/A	N/A	N/A	N/A
Accounts payable and accrued liabilities	2,188	1,172	311	501	0
Accrued Expenses	6,510	4,310	2,006	1,614	N/A
TOTAL	$35,192	$10,370	$12,768	$12,850	$N/A

Non-Current Liabilities
Long Term Debt	N/A	11,279	10,134	N/A	N/A
Deferred Revenues	3,097	4,888	10,451	10,735	N/A
Other Non-Current Liabilities	1,022	1,459	767	11,847	0
TOTAL	$4,274	$19,238	$28,657	$28,834	$N/A

Total Liabilities	$39,466	$29,608	$41,425	$41,684	$N/A

Shareholders' Equity
Shares Outstanding, K	421	360	299	N/A	N/A
Common Shares	49	42	36	N/A	N/A
Retained earnings	-135,767	-79,087	-60,419	-43,011	N/A
Other shareholders' equity	-197	-16	-52	42,624	0
TOTAL	$132,014	$93,457	$62,093	$1,197	$N/A

Total Liabilities And Equity	$171,480	$123,065	$103,518	$42,881	$0